Search Results

Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT imaging systems and clinical services, is pleased to announce its membership in the national alliance “Cardiac PET Industry Coalition”, an organization at the forefront of quality of patient care, advocacy and innovation to advance the field of cardiovascular PET imaging.

Alnylam and BridgeBio are competing for people who are switching from Pfizer’s blockbuster ATTR amyloidosis drug tafamidis while all three companies are fighting for new patients.

Data demonstrates improvement in cardiac function and reductions in cardiac hypertrophy, remodeling, inflammation, and cell death - key underlying mechanisms in heart failure